IL132884A0 - Body protection compound peptide salts with organo-protective activity pharmaceutical and diagnostic compositions containing the same the use thereof and process for preparing the same - Google Patents

Body protection compound peptide salts with organo-protective activity pharmaceutical and diagnostic compositions containing the same the use thereof and process for preparing the same

Info

Publication number
IL132884A0
IL132884A0 IL13288498A IL13288498A IL132884A0 IL 132884 A0 IL132884 A0 IL 132884A0 IL 13288498 A IL13288498 A IL 13288498A IL 13288498 A IL13288498 A IL 13288498A IL 132884 A0 IL132884 A0 IL 132884A0
Authority
IL
Israel
Prior art keywords
same
organo
preparing
compositions containing
body protection
Prior art date
Application number
IL13288498A
Other languages
English (en)
Original Assignee
Sikiric Predrag
Petek Marijan
Seiwerth Sven
Turkovic Branko
Grabarevic Zeljko
Rotkvic Ivo
Mise Stjepan
Duvnjak Marko
Udovicic Ivan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sikiric Predrag, Petek Marijan, Seiwerth Sven, Turkovic Branko, Grabarevic Zeljko, Rotkvic Ivo, Mise Stjepan, Duvnjak Marko, Udovicic Ivan filed Critical Sikiric Predrag
Publication of IL132884A0 publication Critical patent/IL132884A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13288498A 1997-05-23 1998-05-20 Body protection compound peptide salts with organo-protective activity pharmaceutical and diagnostic compositions containing the same the use thereof and process for preparing the same IL132884A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97108384 1997-05-23
PCT/EP1998/002953 WO1998052973A1 (fr) 1997-05-23 1998-05-20 Nouveaux sels de peptides bpc ayant une activite de protection de l'organisme, procede de preparation correspondant et leur utilisation en therapie

Publications (1)

Publication Number Publication Date
IL132884A0 true IL132884A0 (en) 2001-03-19

Family

ID=8226822

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13288498A IL132884A0 (en) 1997-05-23 1998-05-20 Body protection compound peptide salts with organo-protective activity pharmaceutical and diagnostic compositions containing the same the use thereof and process for preparing the same
IL132884A IL132884A (en) 1997-05-23 1999-11-11 Peptide salts of a body preservative compound with preservative-activity activity, pharmaceuticals and diagnostic preparations containing them, their use and process for their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL132884A IL132884A (en) 1997-05-23 1999-11-11 Peptide salts of a body preservative compound with preservative-activity activity, pharmaceuticals and diagnostic preparations containing them, their use and process for their preparation

Country Status (28)

Country Link
US (1) US6288028B1 (fr)
EP (1) EP0983300B1 (fr)
JP (1) JP3492381B2 (fr)
KR (1) KR100488038B1 (fr)
CN (1) CN1166683C (fr)
AR (1) AR011478A1 (fr)
AT (1) ATE277948T1 (fr)
AU (1) AU731317B2 (fr)
BG (1) BG64023B1 (fr)
BR (1) BR9809457B1 (fr)
CA (1) CA2290739C (fr)
CZ (1) CZ299423B6 (fr)
DE (1) DE69826653T2 (fr)
DK (1) DK0983300T3 (fr)
EA (1) EA002058B1 (fr)
ES (1) ES2229507T3 (fr)
HU (1) HU227800B1 (fr)
ID (1) ID23184A (fr)
IL (2) IL132884A0 (fr)
NO (1) NO321126B1 (fr)
NZ (1) NZ501323A (fr)
PL (1) PL193790B1 (fr)
PT (1) PT983300E (fr)
RS (1) RS49733B (fr)
SK (1) SK159599A3 (fr)
TR (1) TR199902866T2 (fr)
UA (1) UA61955C2 (fr)
WO (1) WO1998052973A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005082389A1 (fr) * 2004-02-27 2005-09-09 Fuji Oil Company, Limited Composition inhibitoire pour métastase cancerigène
US8022216B2 (en) * 2007-10-17 2011-09-20 Wyeth Llc Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji
US10350293B2 (en) 2016-08-23 2019-07-16 Pharmacotherapia d.o.o. Compositions and methods for treating symptoms associated with multiple sclerosis
KR102665710B1 (ko) 2017-08-24 2024-05-14 노보 노르디스크 에이/에스 Glp-1 조성물 및 그 용도
JP7761567B2 (ja) 2020-02-18 2025-10-28 ノヴォ ノルディスク アー／エス 医薬製剤
US11065298B1 (en) * 2020-04-24 2021-07-20 Chanda Zaveri Compositions and methods for treating or preventing viral infections
US12605427B2 (en) * 2023-05-15 2026-04-21 Red Mountain Med Spa, LLC Sublingual semaglutide-BPC 157 combination for weight loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6901191A (en) * 1990-09-11 1992-03-30 Marko Duvnjak Pharmacologically active substance bpc, the process for its preparation and its use in the therapy
EP0572688B1 (fr) 1992-05-30 1997-05-07 Predrag Dr.Sc. Sikiric Peptides de BPC, leur préparation et utilisation
CA2127553C (fr) * 1992-11-16 2003-01-28 Predrag Sikiric Peptides ayant une activite organoprotectrice, methode de preparation et leur utilisation en therapeutique

Also Published As

Publication number Publication date
WO1998052973A1 (fr) 1998-11-26
PT983300E (pt) 2005-02-28
HU227800B1 (en) 2012-03-28
AU731317B2 (en) 2001-03-29
DK0983300T3 (da) 2005-01-31
EA002058B1 (ru) 2001-12-24
EP0983300A1 (fr) 2000-03-08
PL193790B1 (pl) 2007-03-30
CZ9904142A3 (cs) 2002-03-13
IL132884A (en) 2007-08-19
AR011478A1 (es) 2000-08-16
YU60199A (sh) 2002-09-19
ATE277948T1 (de) 2004-10-15
RS49733B (sr) 2008-04-04
NO321126B1 (no) 2006-03-20
KR20010012895A (ko) 2001-02-26
JP3492381B2 (ja) 2004-02-03
PL336897A1 (en) 2000-07-17
NO995692L (no) 2000-01-24
HUP0002329A3 (en) 2001-03-28
ID23184A (id) 2000-03-23
AU7914198A (en) 1998-12-11
BR9809457A (pt) 2000-06-20
CA2290739A1 (fr) 1998-11-26
DE69826653D1 (de) 2004-11-04
BR9809457B1 (pt) 2010-11-30
SK159599A3 (en) 2000-11-07
CA2290739C (fr) 2007-06-26
UA61955C2 (en) 2003-12-15
US6288028B1 (en) 2001-09-11
BG103905A (en) 2000-07-31
EA199901061A1 (ru) 2000-06-26
EP0983300B1 (fr) 2004-09-29
ES2229507T3 (es) 2005-04-16
KR100488038B1 (ko) 2005-05-09
CN1257510A (zh) 2000-06-21
NZ501323A (en) 2001-04-27
TR199902866T2 (xx) 2000-02-21
JP2000515558A (ja) 2000-11-21
BG64023B1 (bg) 2003-10-31
HUP0002329A1 (hu) 2000-12-28
CN1166683C (zh) 2004-09-15
CZ299423B6 (cs) 2008-07-23
DE69826653T2 (de) 2006-03-09
NO995692D0 (no) 1999-11-19

Similar Documents

Publication Publication Date Title
IL115483A0 (en) Urea derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL115484A0 (en) Polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
IL115685A (en) Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
IL116211A0 (en) Peptide compounds pharmaceutical compositions containing the same and processes for the preparation thereof
HUP0400932A3 (en) Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same
IL128118A0 (en) Modified amino acids medicaments containing these compounds and processes for their preparation
IL135986A0 (en) Chrysamine g derivatives and pharmaceutical and diagnostic compositions containing the same
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
IL122345A0 (en) Benzamide derivatives their use as vasopressin antagonists processes for the preparation thereof and pharmaceutical compositions containing the same
IL109568A0 (en) Urea derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof
IL113625A0 (en) Amino acid derivatives processes for their preparation and pharmaceutical compositions containing them and their use
IL114670A0 (en) Guanidine derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
HUP9902166A3 (en) Substituted benzamide derivatives having anticonvulsant activity, preparation and use thereof, pharmaceutical compositions containing these compounds
HUP0100853A3 (en) Nitrate salt of anti-ulcer medicine and pharmaceutical compositions containing the same compounds
IL136612A0 (en) Phenylaminoalkylcarboxylic acid derivatives and medical compositions containing the same
IL120924A0 (en) Substituted 2-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
IL132884A0 (en) Body protection compound peptide salts with organo-protective activity pharmaceutical and diagnostic compositions containing the same the use thereof and process for preparing the same
IL115272A0 (en) Asp-pallidipin pharmaceutical compositions containing the same and processes for the preparation thereof
HRP970424B1 (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
ZA989238B (en) Benzimidazole compounds pharmaceutical compositions containing the compounds and their use
GB9518553D0 (en) New urea derivatives processes for the preparation thereof and pharmaceutical composition comprising the same
IL125642A0 (en) Sulfonamide-substituted compounds processes for their preparation their use as a medicament or diagnostic and medicaments comprising them
IL120925A0 (en) Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them
HU9302821D0 (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamide as medical agent

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed